RapidAI is the trusted leader in deep clinical AI, helping hospitals deliver faster, more informed care through intelligent imaging and integrated workflows. The Rapid Enterprise™ Platform supports disease states across the care spectrum, but it’s our clinical depth that drives the most meaningful impact — improving decision-making, patient outcomes, and health-system performance. Used by more than 2,500 hospitals in over 100 countries and backed by 700+ clinical studies, including research that helped expand national stroke-treatment guidelines, RapidAI is the most clinically validated AI platform in healthcare.
RapidAI is seeking a strategic, outcomes-driven leader to help shape and communicate the value of our clinical AI solutions across major health systems and integrated delivery networks (IDNs). This role sits at the critical intersection of commercial strategy, health economics and strategic partnerships, driving enterprise adoption through compelling value narratives and measurable outcomes.
The Director of Market Value & Health Outcomes will translate clinical and operational performance into strategic business value—accelerating revenue growth, supporting payer and provider engagement, and enabling system-wide transformation through ROI frameworks, economic modeling, and executive partnerships.